title: Sulodexide: it is time for a program against chronic venous disease.
authors.affiliation: Institute of Clinical and Experimental Medicine, Prague, Czech Republic - karo@medicon.cz.
authors.forename: K
authors.initials: K
authors.lastname: Roztocil
authors.forename: P L
authors.initials: PL
authors.lastname: Antignani
mesh_terms: D002317:Cardiovascular Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002908:Chronic Disease; D006025:Glycosaminoglycans / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D016896:Treatment Outcome; D014648:Varicose Veins / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D014689:Venous Insufficiency / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology
chemical_list: D002317:Cardiovascular Agents; D006025:Glycosaminoglycans; C007858:glucuronyl glucosamine glycan sulfate